Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bionomics Ltd (BNOEF)

Bionomics Ltd (BNOEF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,452
  • Shares Outstanding, K 1,309,557
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta 1.86
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0027 +25.93%
on 08/30/23
0.0099 -65.66%
on 08/22/23
-0.0065 (-65.66%)
since 08/18/23
3-Month
0.0013 +161.54%
on 08/14/23
0.0260 -86.92%
on 06/23/23
-0.0101 (-74.81%)
since 06/16/23
52-Week
0.0013 +161.54%
on 08/14/23
0.0550 -93.82%
on 11/16/22
-0.0316 (-90.29%)
since 09/16/22

Most Recent Stories

More News
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial

Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment TORONTO, ON / ACCESSWIRE / February 11, 2021 / Novamind Inc. (CSE:NM) ("Novamind"), a leading mental health company...

BNO.AX : 0.010 (unch)
NM.CN : 0.295 (unch)
BNO : 29.47 (+0.68%)
BNOEF : 0.0034 (-43.33%)

Business Summary

Bionomics Limited is a biopharmaceutical company. It discovers and develops drug for the treatment of central nervous system disorders and cancer. The companys product pipeline includes BNC210, a novel and proprietary negative allosteric modulator, which is in Phase II clinical trials; BNC375, a small...

See More

Key Turning Points

3rd Resistance Point 0.0034
2nd Resistance Point 0.0034
1st Resistance Point 0.0034
Last Price 0.0034
1st Support Level 0.0034
2nd Support Level 0.0034
3rd Support Level 0.0034

See More

52-Week High 0.0550
Fibonacci 61.8% 0.0345
Fibonacci 50% 0.0281
Fibonacci 38.2% 0.0218
Last Price 0.0034
52-Week Low 0.0013

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar